Financhill
Back

Bio-Rad Laboratories Quote, Financials, Valuation and Earnings

U.S. Government Report Alert Tuesday

Discover the Secret Loophole
Buy
59

BIO
Bio-Rad Laboratories

Last Price:
367.53
Seasonality Move:
8.09%

7 Day Trial

ALL ACCESS PASS

$ 7

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!

Bio-Rad Laboratories Price Quote

$367.53
-0.89 (-0.24%)
(Updated: November 4, 2024 at 5:55 PM ET)

Bio-Rad Laboratories Key Stats

Buy
59
Bio-Rad Laboratories (BIO) is a Buy

Day range:
$357.30 - $372.27
52-week range:
$262.12 - $372.27
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
4.06
P/B ratio:
1.38%

Volume:
284.3K
Avg. volume:
198.6K
1-year change:
32.76%
Market cap:
$10.3B
Revenue:
$2.7B
EPS:
$-27.33

How Much Does Bio-Rad Laboratories Make?

Is Bio-Rad Laboratories Growing As A Company?

  • What Is Bio-Rad Laboratories's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.03%
  • What Is Bio-Rad Laboratories's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 5.41%

Bio-Rad Laboratories Stock Price Performance

What Is Bio-Rad Laboratories 52-Week High & Low?

Bio-Rad Laboratories Price To Free Cash Flow

Is It Risky To Buy Bio-Rad Laboratories?

Is Bio-Rad Laboratories Cash Flow Positive?

  • What Is BIO Cash Flow From Operations?
    Cash flow from operations (TTM) is $412.1M
  • What Is Bio-Rad Laboratories’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$393.2M
  • What Is Bio-Rad Laboratories’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$57.5M

Bio-Rad Laboratories Return On Invested Capital

  • Is Management Doing A Good Job?
    BIO return on invested capital is -8.38%
  • What Is Bio-Rad Laboratories Return On Assets?
    ROA measures how assets are converting to revenues and is -6.82%
  • What Is BIO Return On Equity?
    ROE is a measure of profitability and is -9.62%

Bio-Rad Laboratories Earnings Date & Stock Price

Bio-Rad Laboratories Competitors

Bio-Rad Laboratories Dividend Yield

Bio-Rad Laboratories Analyst Estimates

YoY Growth Past Surprise
EPS: 541.21% 70.83%
Revenue: 2.79% 3.36%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 399.00
Upside from Last Price: 8.3%

Major Shareholders

  • How many BIO shares are owned by institutional investors?
    27.7M BIO shares are owned by institutional investors
  • How many BIO shares are owned by insiders?
    5.4M BIO shares are owned by insiders